[{"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group: Mobilization of stem cells with the intramuscular administration of IOR\u00ae LEUKOCIM in 4 doses of 10 \u00b5g / kg of weight every 12 hours for 2 days as a strategy to stimulate the hematopoietic system of the patient. With a view to obtaining 400 ml of blood; cell separation and intravenous infusion of 200 x 106 mononuclear cells or more containing at least 1% CD34 + progenitor cells in a single dose.Control Group: Prednisone at a dose of 0.75-1 mg / kg / day; not exceeding a total single dose of 60mg / day during a period of 2 weeks; oral administration;Hematopoietic Stem Cell Mobilization;Prednisone;Injections; Intramuscular;Administration; Oral;IOR\u00ae LEUKOCIM", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group: Mobilization of stem cells with the intramuscular administration of IOR\u00ae LEUKOCIM in 4 doses of 10 \u00b5g / kg of weight every 12 hours for 2 days as a strategy to stimulate the hematopoietic system of the patient. With a view to obtaining 400 ml of blood; cell separation and intravenous infusion of 200 x 106 mononuclear cells or more containing at least 1% CD34 + progenitor cells in a single dose.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Group: Prednisone at a dose of 0.75-1 mg / kg / day; not exceeding a total single dose of 60mg / day during a period of 2 weeks; oral administration;Hematopoietic Stem Cell Mobilization;Prednisone;Injections; Intramuscular;Administration; Oral;IOR\u00ae LEUKOCIM", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 510, "treatment_name": "Filgrastim", "treatment_type": "Csf", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1021, "treatment_name": "Prednisone", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group: Mobilization of stem cells with the intramuscular administration of IOR(R) LEUKOCIM in 4 doses of 10 ug / kg of weight every 12 hours for 2 days as a strategy to stimulate the hematopoietic system of the patient. With a view to obtaining 400 ml of blood; cell separation and intravenous infusion of 200 x 106 mononuclear cells or more containing at least 1% CD34 + progenitor cells in a single dose. Control Group: Prednisone at a dose of 0.75-1 mg / kg / day; not exceeding a total single dose of 60mg / day during a period of 2 weeks; oral administration;Hematopoietic Stem Cell Mobilization;IOR(R) LEUKOCIM", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental Group: Mobilization of stem cells with the intramuscular administration of IOR(R) LEUKOCIM in 4 doses of 10 ug / kg of weight every 12 hours for 2 days as a strategy to stimulate the hematopoietic system of the patient. With a view to obtaining 400 ml of blood; cell separation and intravenous infusion of 200 x 106 mononuclear cells or more containing at least 1% CD34 + progenitor cells in a single dose.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Group: Prednisone at a dose of 0.75-1 mg / kg / day; not exceeding a total single dose of 60mg / day during a period of 2 weeks; oral administration;Hematopoietic Stem Cell Mobilization;IOR(R) LEUKOCIM", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]